Clinically, DEPDC1B expression was upregulated in ESCC and negatively correlated with overall survival of ESCC patients, which was of great value as a marker for early diagnosis and prognosis of these patients. Here, DEPDC1B is linked to esophageal squamous cell carcinoma.